Drops and drugs for diabetic vison loss
Eye injections are the only way to treat diabetic retinopathy, but many refuse to get them. Now, eye drops and pills are on their way.
Ophthalmology
Gene editing: DNA versus RNA
Researchers correcting the genetic causes of disease at the DNA or RNA level make their cases.
A drug that protects against Alzheimer’s disease may help with Wolfram Syndrome
Wolfram Syndrome is a rare disease that causes a myriad of challenges, including deafness, diabetes, and depression. New research suggests that an agonist used to treat neurodegenerative disorders may help alleviate some of the symptoms.
A contact lens with nano-scale needles for drug delivery
Silicon nanoneedles loaded with ocular drugs hold potential to replace invasive injections to the eye.
Stem cell therapy for macular degeneration
Age-related macular degeneration is the most common cause of vision loss in adults over age 50, but there are few treatments available. Researchers are now developing promising stem cell therapies to treat the disease.
Bionic eyes: Treatments for blindness target the retina and the brain
Researchers are developing gene and cell therapies and prosthetics to help patients with blindness regain some vision. The first major prosthetic, the Argus II, was just discontinued. Where will the field go from here?
Safer eye floater treatments come with a burst of nanobubbles
Between invasive surgery or risky laser therapy, people suffering from severe eye floaters have no great treatment options. Now, with the development of a safer and less invasive nanoparticle-based therapy, people with floaters may finally get their vision and quality of life back.
Taking aim at Bcl-xL
Scientists identify a new target for treating age-related eye diseases
Novel neuroprotection from Noveome
Data show full complement ST266 biologic offers better neuroprotection than fractionated formats
A hope for fewer injections
Roche's faricimab injected every 16 weeks proves non-inferior to aflibercept injected every eight weeks in patients with “wet” age-related macular degeneration
